Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Pharmacological Interaction Between Clonidine and 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01136278

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Completed

Start Date: July 2010

Last Update: January 25, 2013

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: The purpose of this study is to determinate the effect of a pre-treatment with centrally acting alpha2-receptor agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). The investigators hypothesize that clonidine will attenuate the subjective and cardiovascular response to MDMA.

Conditions:
  • Mood Disorder
  • Substance-Related Disorders
  • Amphetamine-Related Disorders


Total execution time in seconds: 0.15452194213867